4//SEC Filing
Bodenrader Mark 4
Accession 0000899243-20-030026
CIK 0001805387other
Filed
Oct 29, 8:00 PM ET
Accepted
Oct 30, 8:13 PM ET
Size
5.6 KB
Accession
0000899243-20-030026
Insider Transaction Report
Form 4
Bodenrader Mark
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2020-10-28+65,445→ 65,445 totalExercise: $9.88Exp: 2030-10-28→ Common Stock (65,445 underlying)
Footnotes (1)
- [F1]50% of this option shall vest and become exercisable on October 28, 2022, with the remainder vesting in two (2) equal annual installments thereafter.
Documents
Issuer
Cerevel Therapeutics Holdings, Inc.
CIK 0001805387
Entity typeother
Related Parties
1- filerCIK 0001830371
Filing Metadata
- Form type
- 4
- Filed
- Oct 29, 8:00 PM ET
- Accepted
- Oct 30, 8:13 PM ET
- Size
- 5.6 KB